Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

CONSORT 2010 Explanation And Elaboration: Updated Guidelines For Reporting Parallel Group Randomised Trials.

D. Moher, S. Hopewell, K. Schulz, V. Montori, P. Gøtzsche, P. Devereaux, D. Elbourne, M. Egger, D. Altman
Published 2010 · Medicine
Referenced 1 time by Citationsy Users

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Overwhelming evidence shows the quality of reporting of randomised controlled trials (RCTs) is not optimal. Without transparent reporting, readers cannot judge the reliability and validity of trial findings nor extract information for systematic reviews. Recent methodological analyses indicate that inadequate reporting and design are associated with biased estimates of treatment effects. Such systematic error is seriously damaging to RCTs, which are considered the gold standard for evaluating interventions because of their ability to minimise or avoid bias. A group of scientists and editors developed the CONSORT (Consolidated Standards of Reporting Trials) statement to improve the quality of reporting of RCTs. It was first published in 1996 and updated in 2001. The statement consists of a checklist and flow diagram that authors can use for reporting an RCT. Many leading medical journals and major international editorial groups have endorsed the CONSORT statement. The statement facilitates critical appraisal and interpretation of RCTs. During the 2001 CONSORT revision, it became clear that explanation and elaboration of the principles underlying the CONSORT statement would help investigators and others to write or appraise trial reports. A CONSORT explanation and elaboration article was published in 2001 alongside the 2001 version of the CONSORT statement. After an expert meeting in January 2007, the CONSORT statement has been further revised and is published as the CONSORT 2010 Statement. This update improves the wording and clarity of the previous checklist and incorporates recommendations related to topics that have only recently received recognition, such as selective outcome reporting bias. This explanatory and elaboration document-intended to enhance the use, understanding, and dissemination of the CONSORT statement-has also been extensively revised. It presents the meaning and rationale for each new and updated checklist item providing examples of good reporting and, where possible, references to relevant empirical studies. Several examples of flow diagrams are included. The CONSORT 2010 Statement, this revised explanatory and elaboration document, and the associated website (www.consort-statement.org) should be helpful resources to improve reporting of randomised trials.
This paper references
10.1016/S0140-6736(08)61170-8
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
K. Fox (2008)
10.1503/cmaj.080820
Does analysis using “last observation carried forward” introduce bias in dementia research?
F. Molnar (2008)
10.1056/NEJMoa0804748
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates.
F. Sacks (2009)
10.1016/S0140-6736(05)61034-3
Sample size calculations in randomised trials: mandatory and mystical
K. Schulz (2005)
Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials.
N. Talley (1996)
10.1503/cmaj.1041086
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research
A. Chan (2004)
10.1186/1471-2474-7-64
Effectiveness of low-Dye taping for the short-term treatment of plantar heel pain: a randomised trial
J. A. Radford (2006)
10.1002/14651858.MR000012.PUB3
Randomisation to protect against selection bias in healthcare trials.
R. Kunz (2007)
10.1136/bmj.319.7223.1492
Calculating the number needed to treat for trials where the outcome is time to an event
D. Altman (1999)
10.1016/0020-7292(91)90376-G
Preventing IUCD‐related pelvic infection: The efficacy of prophylactic doxycycline at insertion
Ska Sinei (1990)
the success of blinding reported in a random sample of randomised, placebo controlled trials
D Fergusson (2012)
Quality of full and fi nal publications reporting acute
FJ Bath (2000)
10.1038/bjc.1993.402
Intention to treat--who should use ITT?
J. Lewis (1993)
10.1016/S0016-5085(00)82546-9
Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease.
K. V. Haderslev (2000)
10.1002/14651858.mr000002.pub2
Technical editing of research reports in biomedical journals.
E. Wager (2007)
10.1001/JAMA.297.19.2112
Issues in the registration of clinical trials.
D. Zarin (2007)
10.1056/NEJM198708133170706
Statistical problems in the reporting of clinical trials. A survey of three medical journals.
S. Pocock (1987)
10.1161/01.STR.29.10.2203
Quality of full and final publications reporting acute stroke trials: a systematic review.
F. Bath (1998)
10.7326/0003-4819-116-1-78
A consumer's guide to subgroup analyses.
A. Oxman (1992)
10.1186/1472-6904-3-4
The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903]
E. Mills (2003)
10.1001/JAMA.285.15.2000
Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials.
P. Devereaux (2001)
10.1001/JAMA.1995.03520370096044
Reporting randomized controlled trials. An experiment and a call for responses from readers.
D. Rennie (1995)
The Lancet Handbook of Essential Concepts in Clinical Research
E. Nwose (2007)
10.1136/bmj.310.6993.1495
Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis
P. Gøtzsche (1995)
10.1371/journal.pmed.0040184
Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others
L. Bero (2007)
10.1002/SIM.4780040412
Interim analyses in clinical trials: classical vs. Bayesian approaches.
D. Berry (1985)
10.1136/bmj.310.6985.985
The rhetoric of research
R. Horton (1995)
10.1056/NEJM199207233270406
Cumulative meta-analysis of therapeutic trials for myocardial infarction.
J. Lau (1992)
Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association.
A. Taddio (1994)
10.7326/0003-4819-134-8-200104170-00012
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
D. Altman (2001)
10.1016/S0084-3873(10)79773-X
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
E. M. Quin (2010)
10.1016/S0140-6736(00)02530-7
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
P. Mease (2000)
10.1136/BMJ.308.6924.283
The scandal of poor medical research
D. Altman (1994)
10.1001/JAMA.285.4.437
Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas.
J. Ioannidis (2001)
10.1177/016555159602200503
Obtaining information accurately and quickly: are structured abstracts more efficient?
J. Hartley (1996)
10.1056/NEJME030054
Interpreting incomplete data in studies of diet and weight loss.
J. Ware (2003)
10.1080/09286580701344399
Quality of Reporting of Key Methodological Items of Randomized Controlled Trials in Clinical Ophthalmic Journals
T. Lai (2007)
10.7326/0003-4819-130-12-199906150-00008
Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy
S. Goodman (1999)
10.1056/NEJM199404213301602
A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
A. Fanaroff (1994)
10.1080/00223980209604145
The Accuracy of Abstracts in Psychology Journals
A. Harris (2002)
10.1191/1740774504cn032oa
Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals
A. Wood (2004)
10.1136/bmj.b2684
Effect of unsupervised home based proprioceptive training on recurrences of ankle sprain: randomised controlled trial
Maarten D. W. Hupperets (2009)
10.3310/HTA9380
The causes and effects of socio-demographic exclusions from clinical trials.
C. Bartlett (2005)
Masking or blinding? An unscientific survey of mostly medical journal editors on the great debate.
T. Lang (2000)
10.1007/s00784-002-0188-x
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
D. Moher (2003)
10.1002/j.1552-4604.1998.tb04444.x
Independence and Statistical Inference in Clinical Trial Designs: A Tutorial Review
S. Bolton (1998)
10.1016/S0002-9394(14)70422-2
Improving the quality of reporting of randomized controlled trials. The CONSORT statement.
C. Begg (1996)
Ef fi cacy of ISA 247 in plaque psoriasis : a randomised , multicentre , double - blind , placebo - controlled phase III study
K Dickersin (2008)
10.1056/NEJM197912273012602
Controversy in counting and attributing events in clinical trials.
D. Sackett (1979)
10.1016/S0140-6736(04)16043-1
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data
C. Whittington (2004)
10.1016/0197-2456(95)00263-4
Blinding during data analysis and writing of manuscripts.
P. Gøtzsche (1996)
10.1002/SIM.4780030421
Why do we need some large, simple randomized trials?
S. Yusuf (1984)
10.1016/S0140-6736(04)17670-8
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
P. Rothwell (2005)
10.1002/(SICI)1099-0496(200001)29:1<1::AID-PPUL1>3.0.CO;2-1
Randomized controlled trials in cystic fibrosis (1966–1997) categorized by time, design, and intervention
K. Cheng (2000)
10.1177/009286159002400312
Baseline Comparability in Clinical Trials: Prevention of “Poststudy Anxiety”
G. G. Enas (1990)
10.1016/S0084-3741(10)79555-X
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
R. Ness-Abramof (2010)
10.1001/JAMA.288.3.358
The continuing unethical conduct of underpowered clinical trials.
S. Halpern (2002)
10.1056/NEJM198806303182605
An assessment of clinically useful measures of the consequences of treatment.
A. Laupacis (1988)
10.1097/01.blo.0000218736.23506.fe
Misuse of Baseline Comparison Tests and Subgroup Analyses in Surgical Trials
M. Bhandari (2006)
10.1177/070674370204700111
The Case of the Missing Data: Methods of Dealing with Dropouts and other Research Vagaries
D. Streiner (2002)
10.1017/S0022215100140770
A qualitative assessment of randomized controlled trials in otolaryngology.
K. Ah-See (1998)
10.1016/S0140-6736(08)61060-0
Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet
Sanaa Al-Marzouki (2008)
10.1177/1740774507081223
The intention-to-treat approach in randomized controlled trials: Are authors saying what they do and doing what they say?
J. Gravel (2007)
10.1177/016327870202500104
Development of the Cochrane Collaboration’s Central Register of Controlled Clinical Trials
K. Dickersin (2002)
10.1001/JAMA.290.7.921
Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
B. Als-Nielsen (2003)
ethical principle for medical research involving human subjects
World Medical Association. Declaration of Helsinki (2009)
10.1001/JAMA.285.15.2006
CONSORT revised--improving the reporting of randomized trials.
D. Rennie (2001)
10.7326/0003-4819-141-10-200411160-00009
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
J. Ioannidis (2004)
10.2307/2531962
Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.
N. Geller (1987)
10.1136/thx.39.11.818
Effect of encouragement on walking test performance.
G. Guyatt (1984)
10.1161/01.CIR.64.4.669
The randomized clinical trial: bias in analysis.
G. May (1981)
10.1136/bmj.312.7033.742
Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology
K. Schulz (1996)
10.1136/bmj.a2299
Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols
A. Chan (2008)
10.1186/1471-2288-1-2
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
D. Moher (2001)
10.7326/0003-4819-132-11-200006060-00002
Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement
J. Heit (2000)
10.1001/JAMA.279.7.545
Users' guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Group.
A. Dans (1998)
10.1136/BMJ.317.7155.362
Minimisation: the platinum standard for trials?
T. Treasure (1998)
10.1016/S0140-6736(99)03464-9
The agonising negative trend in monitoring of clinical trials
D. Demets (1999)
10.1200/JCO.1991.9.1.191
Median follow-up in clinical trials.
J. Shuster (1991)
Statistics in medical journals. Stat Med 1982;1:59e71
DG Altman (1982)
Clinical trials and meta-analyses
DG Altman (2000)
10.1191/1740774504cn014oa
Treatment effects monitoring committees and early stopping in large clinical trials
A. Kiri (2004)
10.1136/BMJ.311.7003.485
Statistics notes: Absence of evidence is not evidence of absence
D. Altman (1995)
10.2471/BLT.07.045120
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
E. von Elm (2007)
10.1146/annurev.publhealth.031308.100223
Adaptive designs for randomized trials in public health.
C. H. Brown (2009)
10.1001/JAMA.1970.03170120039008
Joint study of extracranial arterial occlusion. V. Progress report of prognosis following surgery or nonsurgical treatment for transient cerebral ischemic attacks and cervical carotid artery lesions.
W. Fields (1970)
10.1097/AOG.0b013e31816521e2
Uterine Exteriorization Compared With In Situ Repair at Cesarean Delivery: A Randomized Controlled Trial
I. Coutinho (2008)
10.1016/S0895-4356(02)00446-8
In the dark: the reporting of blinding status in randomized controlled trials.
V. Montori (2002)
10.1111/j.1471-0528.1998.tb10004.x
A randomised controlled trial of care of the perineum during second stage of normal labour
R. McCandlish (1998)
Randomized clinical trials in HEPATOLOGY: predictors of quality. Hepatology 1999;30:1134e8
LL Kjaergard (1999)
10.1371/journal.pone.0003081
Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
K. Dwan (2008)
10.1016/S0140-6736(00)02605-2
The uncertainty principle and industry-sponsored research
B. Djulbegovic (2000)
10.1111/J.1445-2197.1982.TB06050.X
Misuse of statistical methods in the Australasian surgical literature.
J. Hall (1982)
10.1016/S0140-6736(96)90538-3
Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews
D. Moher (1996)
10.1016/S1040-1741(08)79204-2
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review
N. Hanna (2008)
10.1016/S0140-6736(00)02527-7
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
M. Brown (2000)
10.1186/1745-6215-8-39
Standardising outcomes for clinical trials and systematic reviews
M. Clarke (2007)
10.1016/S0140-6736(05)65648-6
CONSORT
N. Black (1996)
10.1136/bmj.313.7057.628
Logistic regression models used in medical research are poorly presented
R. Bender (1996)
10.1136/bmj.321.7257.329
Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety
C. Bolliger (2000)
Factors associated with fi ndings of published trials of drug - drug comparisons : why some statins appear more ef fi cacious than others
L Bero (2002)
10.1136/bmj.295.6599.654
Reference bias in reports of drug trials.
P. Gøtzsche (1987)
10.1001/JAMA.273.5.408
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.
K. Schulz (1995)
10.1212/WNL.44.1.16
The impact of blinding on the results of a randomized, placebo‐controlled multiple sclerosis clinical trial
J. Noseworthy (1994)
10.1016/S0895-4356(00)00227-4
Reporting the study populations of clinical trials. Clear transmission or static on the line?
S. Shapiro (2000)
10.1136/bmj.b1732
Reporting of sample size calculation in randomised controlled trials: review
P. Charles (2009)
10.1136/BMJ.313.7061.862
Statistics notes: Interaction 3: How to examine heterogeneity
J. N. Matthews (1996)
10.1016/S0140-6736(09)61375-1
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
A. Astrup (2009)
10.1258/JRSM.99.7.337
From optimism to disillusion about commitment to transparency in the medico-industrial complex.
I. Chalmers (2006)
10.1097/00006254-199805000-00010
Randomised Controlled Trial of Magnetic-Resonance Pelvimetry in Breech Presentation at Term
A. V. Loon (1998)
10.1016/S0140-6736(00)02712-4
Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial
M. Levin (2000)
10.1001/JAMA.294.17.2203
Randomized trials stopped early for benefit: a systematic review.
V. Montori (2005)
10.1093/IJE/DYM087
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.
J. Pildal (2007)
10.1016/S0197-2456(00)00046-5
Statistical considerations in the intent-to-treat principle.
J. Lachin (2000)
10.1001/JAMA.1966.03100130097026
Statistical evaluation of medical journal manuscripts.
S. Schor (1966)
10.7326/0003-4819-133-7-200010030-00010
Low-Dose Hydrochlorothiazide and Preservation of Bone Mineral Density in Older Adults
A. LaCroix (2000)
10.1016/S1551-7977(10)79326-2
Splint for Base-of-Thumb Osteoarthritis: A Randomized Trial
M. Outzen (2010)
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials.
S. Veldhuyzen van Zanten (1996)
10.1001/JAMA.281.12.1110
Accuracy of data in abstracts of published research articles.
R. Pitkin (1999)
10.1016/S0039-6060(96)80149-8
Methodologic standards in surgical trials.
J. Hall (1996)
Missing outcomes in randomized trials: addressing the dilemma
D. Altman (2009)
10.7326/0003-4819-136-3-200202050-00022
The Landscape and Lexicon of Blinding in Randomized Trials
K. Schulz (2002)
10.1001/JAMA.289.16.2128
Stopping medical research to save money: a broken pact with researchers and patients.
B. Psaty (2003)
10.1016/S0140-6736(98)00379-1
Trials stopped early: too good to be true?
S. Pocock (1999)
10.1136/bmj.323.7303.42
Assessing the quality of controlled clinical trials
P. Jüni (2001)
10.1038/bjc.1995.364
Review of survival analyses published in cancer journals.
D. Altman (1995)
10.4135/9781848608344.n21
Publication and related biases.
F. Song (2000)
10.1001/JAMA.1987.03390090119041
Clinical Trials: Design, Conduct, and Analysis
L. Baker (1987)
10.1038/bjc.1976.220
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.
R. Peto (1976)
10.1136/bmj.318.7193.1224
The case for structuring the discussion of scientific papers
M. Docherty (1999)
10.1177/1740774506069153
Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors
M. Haahr (2006)
10.1016/0009-9236(95)90260-0
Intention‐to‐treat analysis and the goals of clinical trials
L. Sheiner (1995)
10.1136/bmj.310.6977.452
The number needed to treat: a clinically useful measure of treatment effect
R. Cook (1995)
10.1002/SIM.2025
Identification and impact of outcome selection bias in meta-analysis.
P. Williamson (2005)
Who bene fi ts from medical interventions ?
FA McAlister (1994)
10.1136/bmj.38414.422650.8F
Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study
J. Pildal (2005)
10.1136/bmj.325.7358.249
Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ
L. L. Kjaergard (2002)
10.1136/bmj.b1867
Supplementary feeding with either ready-to-use fortified spread or corn-soy blend in wasted adults starting antiretroviral therapy in Malawi: randomised, investigator blinded, controlled trial
M. Ndekha (2009)
10.1002/1097-0258(20001230)19:24<3325::AID-SIM827>3.0.CO;2-D
Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies.
S. Hahn (2000)
10.1016/S0140-6736(97)08447-X
Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis
T. Kiviluoto (1998)
10.1016/0197-2456(88)90046-3
Properties of simple randomization in clinical trials.
J. Lachin (1988)
10.7326/0003-4819-136-2-200201150-00009
Reporting on Statistical Methods To Adjust for Confounding: A Cross-Sectional Survey
M. Mllner (2002)
10.1186/1471-2288-3-19
The reporting of methods for reducing and detecting bias: an example from the WHO Misoprostol Third Stage of Labour equivalence randomised controlled trial
G. Piaggio (2003)
10.1186/1745-6215-9-20
Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'
S. Hopewell (2008)
10.1136/bmj.317.7167.1191
Reporting on quality of life in randomised controlled trials: bibliographic study
C. Sanders (1998)
10.1016/S0022-3476(94)90001-9
A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infant
A. Fanaroff (1994)
10.1371/journal.pmed.0040102
Impact and Process Evaluation of Integrated Community and Clinic-Based HIV-1 Control: A Cluster-Randomised Trial in Eastern Zimbabwe
S. Gregson (2007)
10.1002/1097-0258(20000730)19:14<1849::AID-SIM506>3.0.CO;2-1
Estimating treatment effects in randomized clinical trials in the presence of non-compliance.
N. Nagelkerke (2000)
10.1136/bmj.311.7013.1145
Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons
M. Campbell (1995)
Confidence intervals in practice
DG Altman (2000)
10.1177/014107689709000706
Assembling Comparison Groups to Assess the Effects of Health care *
Lain Chalmers (1997)
10.2214/AJR.183.6.01831539
Randomized controlled trials.
H. Stolberg (2004)
10.1136/bmj.a2390
Improving the reporting of pragmatic trials: an extension of the CONSORT statement
M. Zwarenstein (2008)
10.7326/0003-4819-144-5-200603070-00013
Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement
J. Gagnier (2006)
10.1136/bmj.317.7168.1309
Confidence intervals for the number needed to treat
D. Altman (1998)
10.7326/0003-4819-117-11-916
Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?
C. Naylor (1992)
Adjustment for covariate imbalance
DG Altman (1998)
10.1111/j.1471-0528.2000.tb11091.x
A randomised controlled trial and meta‐analysis of active management of labour
L. Sadler (2000)
10.1192/BJP.176.3.249
Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia.
M. Marshall (2000)
The case for structuring the discussion of scienti fi c papers
GP Purcell (1999)
PhRMAWorking Group on adaptive designs , “ White Paper ”
CH Brown (2006)
10.1001/JAMA.285.15.1996
Value of flow diagrams in reports of randomized controlled trials.
M. Egger (2001)
10.1002/SIM.4780060320
Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials.
T. Chalmers (1987)
10.1258/JRSM.100.4.187
Reports of clinical trials should begin and end with up-to-date systematic reviews of other relevant evidence: a status report.
M. Clarke (2007)
10.1056/NEJM199912093412404
Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.
A. Sandler (1999)
10.2106/JBJS.H.01481
Intention-to-treat analysis and accounting for missing data in orthopaedic randomized clinical trials.
A. Herman (2009)
10.1001/jama.299.17.2027
Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
Christine M. Albert (2008)
10.1002/9780470693926.CH19
Applying the Results of Systematic Reviews at the Bedside
F. McAlister (2008)
10.1001/JAMA.280.3.247
Adherence to published standards of reporting: a comparison of placebo-controlled trials published in English or German.
C. Junker (1998)
10.1001/JAMA.289.14.1833
Effects of Internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial.
D. Tate (2003)
10.1097/01.aids.0000189866.67182.f7
Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols
M. Gandhi (2005)
10.1016/S0140-6736(08)61242-8
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
S. Yusuf (2008)
10.1177/096228020000900103
Promoting good research practice
G. Murray (2000)
Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding? Clin Trials 2005;2:218e29
D Fergusson (2005)
10.1136/bmj.39465.451748.AD
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
L. Wood (2008)
10.1001/JAMA.1975.03240220018013
Ascorbic acid for the common cold. A prophylactic and therapeutic trial.
T. Karlowski (1975)
trials : a systematic review
JL Blumer (1998)
Quality of randomised clinical trials affects estimates of intervention efficacy
LL Kjaergard (1999)
Measuring Health: A Guide to Rating Scales and Questionnaires
Kate L Hyett (2006)
10.1016/J.JCLINEPI.2006.09.011
Limitations are not properly acknowledged in the scientific literature.
J. Ioannidis (2007)
Somato - statin v placebo in bleeding oesophageal varices : randomised trial and meta - analysis
M Clarke (1995)
10.1186/1471-2288-6-56
Checklist for the qualitative evaluation of clinical studies with particular focus on external validity and model validity
G. Bornhöft (2006)
10.1136/bmj.326.7400.1171
Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications
H. Melander (2003)
10.1136/bmj.b4074
Supervised exercise therapy versus usual care for patellofemoral pain syndrome: an open label randomised controlled trial
R. van Linschoten (2009)
10.1016/S0140-6736(94)92407-4
Completeness of reporting trial results: effect on physicians' willingness to prescribe
M. Bobbio (1994)
10.1136/bmj.314.7098.1907a
Quoting intermediate analyses can only mislead
J. Bland (1997)
So what’s so special about randomisation
J Kleijnen (1997)
Assessment of general - isability in trials of health interventions : suggested framework and systematic review
C Bonell (2006)
PhRMAWorking Group on adaptive designs , “ White Paper ”
CH Brown (2006)
Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age. Pediatrics 2009;123:e770e6
JL Blumer (2009)
Comparability of randomised groups. Statistician 1985;34:125e36
DG Altman (1985)
10.3310/HTA9070
Issues in data monitoring and interim analysis of trials.
A. Grant (2005)
10.1136/bmj.315.7109.635
Impact of covert duplicate publication on meta-analysis: a case study
M. Tramèr (1997)
10.1001/jama.2009.788
Prevention of depression in at-risk adolescents: a randomized controlled trial.
J. Garber (2009)
10.1016/S0140-6736(00)02039-0
Subgroup analysis and other (mis)uses of baseline data in clinical trials
S. Assmann (2000)
10.3310/HTA9350
Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.
M. King (2005)
Intention-to-treat analysis: who is in? Who is out?
R. Kruse (2002)
10.1136/bmj.38895.410451.79
Believability of relative risks and odds ratios in abstracts: cross sectional study
P. Gøtzsche (2006)
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341e5
CJ Whittington (2004)
10.1503/CMAJ.050600
Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors
C. D. De Angelis (2005)
10.1001/JAMA.1989.03430150069028
Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis.
A. Nicolucci (1989)
10.1136/BMJ.320.7240.1007
Intention to treat analysis is related to methodological quality
M. Ruíz-Canela (2000)
10.1186/1472-6947-8-31
Laypersons' understanding of relative risk reductions: Randomised cross-sectional study
L. Sørensen (2008)
10.7326/0003-4819-121-3-199408010-00008
The Use of Predicted Confidence Intervals When Planning Experiments and the Misuse of Power When Interpreting Results
S. Goodman (1994)
10.1056/NEJMoa0807611
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.
Pim A. L. Tonino (2009)
10.1136/bmj.317.7167.1181
Content and quality of 2000 controlled trials in schizophrenia over 50 years
B. Thornley (1998)
10.1136/BMJ.37952.631667.EE
Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
D. Fergusson (2004)
10.1001/JAMA.279.18.1487
Beyond CONSORT: need for improved reporting standards for clinical trials. Consolidated Standards of Reporting Trials.
C. Meinert (1998)
Treatment of attentiondeficit/hyperactivity disorder
AR Jadad (1999)
10.1136/bmj.313.7069.1390
Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability
J. Savulescu (1996)
10.1016/0140-6736(90)90014-V
Randomisation and baseline comparisons in clinical trials
D. Altman (1990)
10.1200/JCO.1986.4.10.1529
Publication bias: the case for an international registry of clinical trials.
R. Simes (1986)
10.1177/009286159803200102
Technologies for Automating Randomized Treatment Assignment in Clinical Trials
U. Haag (1998)
10.1089/acm.2007.0818
Evidence-based approaches for the Ayurvedic traditional herbal formulations: toward an Ayurvedic CONSORT model.
S. Narahari (2008)
10.1136/bmj.39590.732037.47
What is missing from descriptions of treatment in trials and reviews?
P. Glasziou (2008)
Con fi dence intervals for the number needed to treat
DG Altman (1998)
10.4065/83.7.747
Chronic care model and shared care in diabetes: randomized trial of an electronic decision support system.
S. Smith (2008)
Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis
Hupperets (1998)
10.1016/S0140-6736(08)60593-0
Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study
K. Papp (2008)
10.1002/9781118183335.CH2
Fundamentals of Clinical Trials
G. Yin (2012)
10.2307/2987510
Comparability of Randomised Groups
D. Altman (1985)
Lack of bene fi t of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder
AD Sandler (2007)
10.1001/jama.299.15.1800
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
J. Ross (2008)
10.1002/SIM.2631
FDA perspective on trials with interim efficacy evaluations.
R. Temple (2006)
10.1001/ARCHDERM.136.3.381
How well are randomized controlled trials reported in the dermatology literature?
K. Adetugbo (2000)
Systematic reviews in health care: assessing the quality of controlled clinical trials
P Jüni (2001)
How important is publication bias? A synthesis of available data.
K. Dickersin (1997)
Value of fl ow diagrams in reports of randomized controlled trials
M Egger (2001)
10.1136/BMJ.328.7448.1136-A
Turning a blind eye:Why we don't test for blindness at the end of our trials
D. Sackett (2004)
10.1191/1740774505cn085oa
Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?
D. Fergusson (2005)
10.1111/1467-9884.00369_22
Cross‐over Trials in Clinical Research
A. Rigby (2003)
10.1002/SIM.4780071204
Stopping rules and estimation problems in clinical trials.
M. Hughes (1988)
10.1136/bmj.319.7211.670
What is meant by intention to treat analysis? Survey of published randomised controlled trials
S. Hollis (1999)
Factors relevant to the validity of experiments in social settings
PM Rothwell (1957)
10.1016/S0140-6736(00)03651-5
Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials
R. Collins (2001)
10.3109/10601339509019426
Base Logic: Tests of Baseline Balance in Randomized Clinical Trials
S. Senn (1995)
10.1126/SCIENCE.333584
Some thoughts on clinical trials, especially problems of multiplicity.
J. Tukey (1977)
10.1056/NEJM199805073381911
Masked monitoring in clinical trials--blind stupidity?
C. Meinert (1998)
10.1056/NEJMoa0901301
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
S. Connolly (2009)
10.1371/journal.pctr.0010009
Factors That Can Affect the External Validity of Randomised Controlled Trials
P. Rothwell (2006)
10.1001/JAMA.1994.03520020048013
Statistical power, sample size, and their reporting in randomized controlled trials.
D. Moher (1994)
Design and analysis of randomized clinical trials requiring prolonged observation of each patient
R Peto (1976)
10.1371/JOURNAL.PMED.0020298
Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial
B. Auvert (2005)
10.1136/bmj.321.7259.504
Blinding in clinical trials and other studies
S. Day (2000)
10.1016/S0140-6736(96)01201-9
Randomised trials, human nature, and reporting guidelines
K. Schulz (1996)
10.1136/BMJ.314.7098.1874
Statistics Notes: Units of analysis
D. Altman (1997)
10.7326/0003-4819-118-3-199302010-00009
The Risk of Determining Risk with Multivariable Models
J. Concato (1993)
10.1016/S0895-4356(97)00240-0
A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group.
A. Fuks (1998)
10.1186/1745-6215-10-50
Intravenous fluid restriction after major abdominal surgery: a randomized blinded clinical trial
H. Vermeulen (2009)
10.1136/bmj.1.6053.85
Misuse of statistical methods: critical assessment of articles in BMJ from January to March 1976.
S. Gore (1977)
10.1136/bmj.305.6847.235
When to stop a clinical trial.
S. Pocock (1992)
10.1016/0736-4679(87)90192-2
Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1
D. Lemon (1987)
10.5694/j.1326-5377.2006.tb00557.x
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review
A. Plint (2006)
10.1136/bmj.333.7563.346
Assessment of generalisability in trials of health interventions: suggested framework and systematic review
C. Bonell (2006)
10.1136/ebmh.11.1.3-a
Missing data and the trouble with LOCF
D. Streiner (2008)
10.7326/0003-4819-108-2-266
Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations.
J. C. Bailar (1988)
Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention - de fi cit / hyperactivity disorder in children 6 to 17 years of age
MS Sabatine (2009)
10.1136/bmj.286.6376.1489
Statistical guidelines for contributors to medical journals.
D. Altman (1983)
10.1136/bmj.a2664
Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial
A. Grant (2008)
Intravenous fl uid restriction after major abdominal surgery : a randomized blinded clinical trial
H Vermeulen (2004)
Registering clinical trials.
I. Leviton (2003)
10.1016/S0140-6736(08)61242-8
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
The Telmisartan Randomised AssessmeNt Study in Ace iNt Investigators (2008)
10.1001/JAMA.1991.03470010097038
Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.
S. Yusuf (1991)
10.7326/0003-4819-133-9-200011070-00009
Comparison of Oral Fluconazole and Itraconazole for Progressive, Nonmeningeal Coccidioidomycosis
J. Galgiani (2000)
10.1136/bmj.321.7252.20
An open prospective randomised trial to reduce the pain of blood glucose testing: ear versus thumb
S. Carley (2000)
10.1136/bmj.313.7052.275
Guidelines for authors and peer reviewers of economic submissions to the BMJ
M. Drummond (1996)
10.1001/archinternmed.2007.30
Generalizability of the results of randomized trials.
N. Weiss (2008)
Early versus delayed neonatal administration of a synthetic surfactant d the judgment of OSIRIS ( open study of infants at high risk of or with respiratory insuf fi ciency d the role of surfactant )
L Sorensen (1992)
10.1016/0197-2456(89)90017-2
Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis.
P. Gøtzsche (1989)
10.1136/bmj.321.7266.931
Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial
L. Diggle (2000)
10.1056/NEJMOA070829
Optimal medical therapy with or without PCI for stable coronary disease.
W. Boden (2007)
10.1136/bmj.a339
Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial
J. Webster (2008)
10.1016/S0140-6736(09)61454-9
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial
M. Sabatine (2009)
10.1093/IJE/29.1.158
Principles of multilevel modelling.
S. Greenland (2000)
Explanation and Elaboration
J. Vandenbroucke
Structured abstracts in MEDLINE, 1989-1991.
A. M. Harbourt (1995)
10.1016/J.CCT.2007.08.001
Pharmaceutical company funding and its consequences: a qualitative systematic review.
S. Sismondo (2008)
Modified intention to treat: frequency, definition and implication for clinical trials
I Abraha (2007)
Comparison of oral fl uconazole and itraconazole for progressive , non - meningeal coccidioidomycosis . A randomized , double - blind trial . Mycoses Study Group
JN Galgiani (1994)
10.1136/BMJ.325.7376.1314
A clinical trials register for Europe
A. Tonks (2002)
10.1353/BHM.1998.0159
Intentional Ignorance: A History of Blind Assessment and Placebo Controls in Medicine
T. Kaptchuk (1998)
10.2307/2988097
Statistical Aspects of Clinical Trial Design
S. Pocock (1982)
10.1001/JAMA.276.16.1339
Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.
J. Siegel (1996)
10.1191/1740774504cn003oa
Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study
M. Sydes (2004)
10.1002/PST.267
Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches.
P. Lane (2008)
10.1016/S0140-6736(08)60601-7
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial
P. J. Devereaux (2008)
10.1136/bmj.c723
The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed
S. Hopewell (2010)
10.7326/0003-4819-148-4-200802190-00008
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
I. Boutron (2008)
10.1001/JAMA.279.18.1489
CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials.
D. Moher (1998)
vedilol for children and adolescents with heart failure : a randomized controlled trial
RE Shaddy (2007)
10.1097/01.AOG.0000298338.58511.d1
Multicenter Comparison of the Contraceptive Ring and Patch: A Randomized Controlled Trial
M. Creinin (2008)
10.1200/JCO.2005.05.3959
Adverse event reporting in publications compared with sponsor database for cancer clinical trials.
Orit Scharf (2006)
Randomization, statistics, and causal inference. Epidemiology 1990;1:421e9
S. Greenland (1990)
10.1056/NEJMoa067373
Vasopressin versus norepinephrine infusion in patients with septic shock.
J. Russell (2008)
10.1001/JAMA.291.20.2457
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.
A. Chan (2004)
10.1081/BIP-200062859
A Practical Comparison of Group-Sequential and Adaptive Designs
P. Kelly (2005)
10.1136/bmj.319.7211.703
How to randomise
D. Altman (1999)
PhRMAWorking Group on adaptive designs, “White Paper
P Gallo (2006)
Statement : updated guidelines for reporting parallel group randomised trials
SJ Pocock (2010)
10.1038/nm0697-692
How to Report Statistics in Medicine
E. Franssen (1997)
CONSORT for reporting randomised trials in journal and conference abstracts
T. Wachs (2008)
10.1016/S0140-6736(00)04560-8
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.
H. Dargie (2001)
10.1001/JAMA.289.19.2545
Analysis and reporting of factorial trials: a systematic review.
F. McAlister (2003)
10.1345/aph.1D416
Accuracy of Abstracts for Original Research Articles in Pharmacy Journals
Leah G Ward (2004)
10.1148/RADIOL.2261021292
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative.
P. Bossuyt (2003)
10.1001/JAMA.298.10.1171
Carvedilol for children and adolescents with heart failure: a randomized controlled trial.
R. Shaddy (2007)
10.1002/SIM.4780101011
Analysis of clinical trials by treatment actually received: is it really an option?
Y. J. Lee (1991)
10.1016/S0029-7844(98)00537-7
Logistic regression models in obstetrics and gynecology literature.
K. Khan (1999)
10.1136/bmj.328.7441.702
CONSORT statement: extension to cluster randomised trials
M. Campbell (2004)
10.1136/bmj.326.7400.1167
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
J. Lexchin (2003)
10.1002/SIM.4780120517
Interim analyses, stopping rules and data monitoring in clinical trials in Europe.
M. Buyse (1993)
10.1016/J.IJSU.2010.09.006
WITHDRAWN: CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
K. Schulz (2010)
10.2307/2981516
Clinical Trials: A Practical Approach
M. Palmer (1985)
10.1016/S0002-8703(00)90001-2
Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics?
E. Steyerberg (2000)
10.1371/journal.pmed.0050004
In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter?
G. Guyatt (2008)
10.1056/NEJM198206033062204
Reporting on methods in clinical trials.
R. Dersimonian (1982)
10.1136/BMJ.313.7060.808
Statistics Notes: Interaction 2: compare effect sizes not P values
J. N. Matthews (1996)
10.1001/JAMA.280.3.227
Changes to manuscripts during the editorial process: characterizing the evolution of a clinical paper.
G. P. Purcell (1998)
10.1056/NEJM199406163302415
More on zidovudine in asymptomatic HIV infection.
D. Altman (1994)
10.7326/0003-4819-113-1-69
More informative abstracts revisited.
R. Haynes (1996)
10.1016/S0140-6736(07)60714-4
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review
D. Gilligan (2007)
10.1056/NEJM197809282991304
The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.
J. A. Freiman (1978)
The randomized clinical trial: bias in analysis. Circulation 1981;64:669e73
GS May (1981)
10.1136/bmj.308.6921.72
Who benefits from medical interventions?
G. Smith (1994)
10.7326/0003-4819-133-3-200008010-00017
News from the International Committee of Medical Journal Editors
F. Davidoff (2000)
10.1001/jama.296.15.1842
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.
G. Piaggio (2006)
10.1001/archinternmed.2009.306
Reporting of safety results in published reports of randomized controlled trials.
I. Pitrou (2009)
10.1001/JAMA.1995.03530180050029
Subverting randomization in controlled trials.
K. Schulz (1995)
10.1037/H0040950
Factors relevant to the validity of experiments in social settings.
D. Campbell (1957)
Methodologic standards in surgical trials. Surgery 1996;119:466e72
JC Hall (1996)
10.1001/JAMA.1994.03520020051014
Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals.
K. Schulz (1994)
10.1016/S0140-6736(05)71879-1
Epidemiology and reporting of randomised trials published in PubMed journals
A. Chan (2005)
10.3310/HTA7270
Evaluating non-randomised intervention studies.
J. Deeks (2003)
10.1136/bmj.292.6522.746
Confidence intervals rather than P values: estimation rather than hypothesis testing.
M. J. Gardner (1986)
10.1002/SIM.4780010412
The role of randomization in clinical trials.
P. Armitage (1982)



This paper is referenced by
10.1007/s00330-015-4164-7
The effectiveness of acupuncture as a treatment for tinnitus: a randomized controlled trial using 99mTc-ECD SPECT
M. R. Laureano (2015)
10.26603/IJSPT20180943
THE START-TO-RUN DISTANCE AND RUNNING-RELATED INJURY AMONG OBESE NOVICE RUNNERS: A RANDOMIZED TRIAL.
Michael Leibach Bertelsen (2018)
10.1007/s00268-014-2580-5
Disclosure of Funding Sources and Conflicts of Interest in Phase III Surgical Trials: Survey of Ten General Surgery Journals
V. Bridoux (2014)
10.1016/j.jmpt.2014.10.001
Manipulative therapy and rehabilitation for recurrent ankle sprain with functional instability: a short-term, assessor-blind, parallel-group randomized trial.
Danella Lubbe (2015)
10.1038/nrclinonc.2015.133
Clinical trials: Subgroup analyses in randomized trials—more rigour needed
D. Altman (2015)
10.1111/cid.12501
Comparison between tapered and cylindrical implants in the posterior regions of the mandible: A prospective, randomized, split‐mouth clinical trial focusing on implant stability changes during early healing
J. Waechter (2017)
Randomized Trial A Randomized , Double-Blind , Active-Controlled Trial of Fluoroscopic Lumbar Interlaminar Epidural Injections in Chronic Axial or Discogenic Low Back Pain : Results of 2-Year Follow-Up
L. Manchikanti (2013)
10.1007/978-981-10-7062-4
Reporting and Publishing Research in the Biomedical Sciences
R. Aggarwal (2018)
10.2340/16501977-2498
Effect of long-term use of ankle-foot orthoses on tibialis anterior muscle electromyography in patients with sub-acute stroke: A randomized controlled trial.
Corien D M Nikamp (2019)
10.1002/bjs.9045
Randomized clinical trial of donor‐site wound dressings after split‐skin grafting
F. E. Brölmann (2013)
10.1016/j.vaccine.2016.05.068
Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals.
S. Fougerolle (2016)
10.14288/1.0363153
The effects of mindfulness and kindness meditation on teacher emotional abilities, compassion, and prosocial behavior
James L. Floman (2018)
Predictors of treatment outcome in exposure therapy for spider phobia
M. Garke (2016)
10.1177/0022034513484337
Patient Risk Factors’ Influence on Survival of Posterior Composites
F.H. van de Sande (2013)
10.1097/SLA.0000000000000835
Nonoperative treatment with antibiotics versus surgery for acute nonperforated appendicitis in children: a pilot randomized controlled trial.
J. Svensson (2015)
10.1515/pp-2016-0026
The quest of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): searching for evidence
M. Reymond (2016)
Lavandula Angustifolia and Melissa Officinalis for agitation management in older adults : a mixed method study
Karen Watson (2017)
10.1186/s12879-016-1739-0
Personalized prescription feedback to reduce antibiotic overuse in primary care: rationale and design of a nationwide pragmatic randomized trial
L. Hemkens (2016)
Enhanced recovery after surgery (ERAS) reduces hospital costs and improve clinical outcomes in liver surgery
Sherrie Rodgers (2020)
10.1179/1743288X11Y.0000000037
A classification and treatment protocol for low back disorders Part 3 – Functional restoration for intervertebral disc related disorders
Jon Joseph Ford (2012)
10.1001/archsurg.2012.150
Influence of rescrubbing before laparotomy closure on abdominal wound infection after colorectal cancer surgery: results of a multicenter randomized clinical trial.
H. Ortiz (2012)
Title Effectiveness of conventional versus virtual reality based vestibular rehabilitation in the treatment of dizziness , gait and balance impairment in adults with unilateral peripheral vestibular loss : A randomised controlled trial
S. Herdman (2012)
10.1007/s00345-011-0646-7
The role of randomized controlled trials in evidence-based urology
L. Lavallée (2011)
The development and evaluation of an mHealth-delivered comprehensive cardiac rehabilitation programme
La Pfaeffli Dale (2016)
10.1016/j.jcma.2017.02.008
Effects of small‐dose dexmedetomidine on hyperdynamic responses to electroconvulsive therapy
X. Li (2017)
Diet and physical activity based interventions in pregnancy : study-level and Individual Participant Data (IPD) meta-analyses
E. Rogozińska (2018)
Evidence based evaluation of immuno-coagulatory interventions in critical care.
A. Afshari (2011)
CHAPTER 5 Ambiguities and Confusions Between Reporting and Conduct
K. Schulz (2014)
Functional Disorders of the Pelvic Floor : assessment of quality of life and management strategies
E. Utomo (2017)
10.9778/cmajo.20160031
Integration of chronic disease prevention and management services into primary care: a pragmatic randomized controlled trial (PR1MaC).
M. Fortin (2016)
10.3109/14992027.2014.892643
A randomized controlled trial evaluating the effects of online rehabilitative intervention for adult hearing-aid users
Elisabet Sundewall Thorén (2014)
10.1017/S1368980015002992
Reducing discretionary food and beverage intake in early childhood: a systematic review within an ecological framework.
B. J. Johnson (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar